输血是外科临床普遍采用的治疗方法 ,但直到 70年代由输血而诱发的对受血者的免疫抑制反应才逐渐引起人们的普遍关注。 2 0多年来 ,国内外学者在这方面进行了大量的研究 ,取得了一定的共识 ,认为输血可缩短癌症患者的术后生存期及使复发时间提前。本文就围手术期输血对肺癌患者 Blood transfusion is a commonly used treatment method in clinical surgery, but it was not until the 70’s that the immunosuppression response to blood recipients induced by blood transfusions gradually attracted people’s attention. For more than 20 years, domestic and foreign scholars have conducted extensive research in this area and have reached a certain consensus that transfusion can shorten the postoperative survival of cancer patients and advance the time of relapse. This article on perioperative blood transfusion for lung cancer patients